To determine whether serotypes of S. pneumoniae isolated from the nasopharynx (NP) are representative of data from patients with invasive disease, we collected NP swab specimens from children, between 3 months and 5 years and obtained data from 105 children hospitalized with invasive disease. The prevalence of penicillin nonsusceptible strains in the NP carriage and invasive disease group was 16.4% and 17%, respectively, in the first period and 42% and 45% in the second period. The serotypes 23F, 6A, 14 and 19F were the most common in the NP study and 14, 1, 5 and 6B were the most common in invasive infections. S treptococcus pneumoniae (SP) is the main etiologic agent of community-acquired pneumonia, and acute otitis media in children, especially in those younger than 5 years of age. Human nasopharyngeal (NP) carriage is the main site of acquisition of pathogenic bacteria in the respiratory tract. [1][2][3] NP colonization with SP is a prerequisite for local and systemic disease. Several studies conducted in Israel, 3 South Africa 4 , Pakistan, 5 Canada 6 and New Guinea 7 confirm that NP colonization with SP, in young children, reflects the serotype distribution and antimicrobial susceptibility of invasive disease isolates.
S
treptococcus pneumoniae (SP) is the main etiologic agent of community-acquired pneumonia, and acute otitis media in children, especially in those younger than 5 years of age. Human nasopharyngeal (NP) carriage is the main site of acquisition of pathogenic bacteria in the respiratory tract. [1] [2] [3] NP colonization with SP is a prerequisite for local and systemic disease. Several studies conducted in Israel, 3 South Africa 4 , Pakistan, 5 Canada 6 and New Guinea 7 confirm that NP colonization with SP, in young children, reflects the serotype distribution and antimicrobial susceptibility of invasive disease isolates.
The main objective of this study was to determine whether serotype distribution and antimicrobial susceptibility of SP isolated from the nasopharynx of children correlated with serotype distribution and antimicrobial susceptibility of invasive isolates. The second objective was to assess the serotype distribution found in NP and invasive pneumococcal disease (IPD) isolates and calculate serotype coverage for the commercial SP heptavalent conjugated vaccine with serotypes 4, 6B, 9V, 14, 18C, 19F, 23F (7V), the investigational vaccine that contains the 7 serotypes plus 1, 5 and 7F (10V) and the other investigational vaccine that contains the 10 serotypes plus 3, 6A and 19A (13V) vaccines.
METHODS
This study was carried out at the pediatric emergency services and pediatrics units of 3 hospitals located in Sao Paulo, Brazil, in patients who had not received pneumococcal vaccine.
Children aged 3 months to 5 years with upper respiratory infections presenting to the pediatric emergency services between June 1997 and May 2001 were eligible for the study. The NP samples were obtained according with the WHO recommendations. 8 For collecting the NP samples, a flexible sterile cotton-tip swab was introduced into the child's nostril to a depth that corresponded to two-thirds of the distance between the nose and the earlobe. The swab was inoculated onto 5% sheep blood agar plate containing 5 g/mL gentamicin, and taken to the bacteriology laboratory on the same day. Alpha-hemolytic colonies exhibiting morphologic characteristics suggestive of S. pneumoniae were isolated. Identification was confirmed by inhibition with optochin and by bile solubility.
Isolates were routinely screened for penicillin resistance with an oxacillin 1 g disk by the Kirby-Bauer disk diffusion method. Organisms with a zone of inhibition Ͻ20 mm were confirmed as penicillin nonsusceptible (PNSP) by minimal inhibitory concentration (MIC) using the penicillin E-test and defined as susceptible, intermediate resistance or high resistance in accordance with Clinical and Laboratory Standards Institute (formally known as NCCLS) guidelines.
All SP strains were serotyped by the Quellung test using sera from the Staten Seroinstitut, Copenhagen, Denmark, at the Instituto Adolfo Lutz, São Paulo, Brazil.
To compare serotypes and penicillin susceptibility data we selected children aged 3 months to 5-year-old diagnosed with IPD, admitted in the same hospitals between 1996 and 2001 identified by review of microbiology records between 1996 and 2001.
Univariate analysis was performed by the 2 test with Yates correction to confirm the significant differences between the groups of colonized and noncolonized children. P Ͻ 0.05 were considered significant. Fisher's exact test was used when expected cell values were Ͻ5.
Proportion of coverage by the heptavalent PCV and the investigational 10 and 13v PCV vaccines were calculated by proportion of serotypes included in the vaccines of all serotypes detected in colonized and infected children.
RESULTS
NP samples were obtained from 520 children, 225 between 3 months and 2 years age and 218 between 2 and 5 years. SP was recovered from 181 children (35% of total). From this total, 109 were from children 3 months to 2 years of age and 72 from children 2 to 5 years of age.
Between 1997 and 1998, NP swabs were obtained from 440 patients. SP was isolated in 139 patients (32%). Between 2000 and 2001, NP swabs were obtained from 80 patients and SP was found in 42 patients (53%). NP colonization was found in 109 (35%) of children 3 months to 2 years of age and in 72 (32%) of those 2-5 years of age.
During the study period, 105 invasive infections were diagnosed in children less than 5 years of age. A total of 55 and 50 IPD isolates were identified in 1996 -1999 and 2000 -2001, respectively. In the first period, 50% of the patients were younger than 2-year-old. In the second period, 64% were younger than 2 years. The sites were pleural fluid, blood culture, CSF and articular fluid (32, 36, 34 and 3 patients, respectively). The diagnoses were pneumonia in 52 children, meningitis in 34, arthritis in 4 and bacteremia in 15. Twenty (14%) and 18 (43%) patients were colonized by PNSP in 1997-1998 and 2000 -2001, respectively. All strains exhibited intermediate susceptibility. Among the invasive infections PNSP was found in 14 of 55 (25.4%) of patients in 1997-1998 and 17 of 50 (34%) of patients in 2000 -2001 . All strains isolated in the first study period exhibited intermediate resistance. High-level resistance was seen in 6 strains (35% of the PNSP) in the second study period.
We identified serotypes in 162 of the 181 SP in NP isolates (120 in the first period and 42 in the second period) and 105 SP in IPD isolates (55 in the first period and 50 in the second period). Serotype distribution for NP and IPD isolates is shown on Table 1 .
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The most frequent serotypes obtained from the nasopharynx were 14, 6B, 23F, 6A and 19F, accounting for 52.8% of all NP isolates. The serotypes 20, 23F and 11A were found only in the first period and serotype 4 was found only in the second period.
Serotype 14 was the most frequent IPD serotype in the 2 periods accounting for 35.5% of all IPD isolates. Serotypes 14, 1, 5 and 23F accounted for 72.5% of the IPD isolates and were the 4 most frequent serotypes in both periods of the study. Serotypes 14, 1 and 5 were significantly more likely to cause invasive disease and serotypes 6A and 11A were significantly more likely to be present only as colonizers (Table 1) .
In pneumonia, the most frequent serotypes were 14 (24), 1 (8) and 6B (4) . In meningitis the most frequent serotypes were 23F (9), 14 (6) and 5 (6) .
Serotype coverage by the 7V vaccine, by the the 10V vaccine and by the 13V vaccine for NP and IPD isolates is shown in Table 1 .
DISCUSSION
Data comparing antibiotic susceptibility between invasive and carriage S. pneumoniae isolates are limited. Kellner et al 6 in Canada and Lehmann et al 7 in Papua New Guinea studied the prevalence of reduced penicillin susceptibility in NP carriage and invasive infections found no difference between the 2 groups.
There are differences in the prevalence and rank order of serotypes between invasive and noninvasive collections and these differences vary depending on the population and geographic location. In our study, the most frequent serotypes obtained from NP were 14, 6B, 19F, 6A and 23F. The most frequent serotypes obtained from PII were 14, 1, 23F and 5. In our study, serotypes 1 and 5 were rare among NP carriage isolates, in contrast to the high prevalence of those serotypes among the isolates causing pediatric invasive disease. It has been well documented that serotypes 1 and 5 are among the most common IPD serotypes in Brazil. 10 It has been hypothesized that, because of their virulence, serotypes 1 and 5 have a transient and fast passage through the nasopharynx before reaching the blood stream. 2 Laval et al 9 in a report from Goiania, Brazil, reported a higher coincidence between serotypes of NP and from IPD isolates probably because in this report the rate of infections by serotype 1 was low. In our series most of infections caused by serotype 1 were pneumonia. The differences in the prevalence and rank order of serotypes between invasive and noninvasive collections vary depending on the population and geographic location. In addition, because PNSP isolates are linked to a limited number of serotypes, any valid comparison of S. pneumoniae isolates from different sites must take serotypes into account.
S. pneumoniae is the most common cause of death worldwide due to a vaccine preventable illness. Vaccination is the best solutions to this problem. Effective vaccines that include serotypes 1 and 5 would be very beneficial preventing more than 90% of IPD cases. Until these investigational vaccines become available, our study demonstrates that we can prevent the majority (66%) of IPD cases in Sao Paulo (Brazil) with the use of the 7V vaccine. 
I
nfluenza transmission was studied 20 years ago using viral culture and serology. Schoolchildren were major introducers of influenza into families, but younger children were also important.
1,2 The difficulty in distinguishing influenza infection acquired at home from that acquired in the community was acknowledged. 2 Today, more young children spend time in out-of-home care and may have overtaken older school age children as the primary source of influenza transmission in communities. 3 Polymerase chain reaction (PCR) based assay enables nucleotide sequencing of different strains. 4 Nonsynonymous nucleotide substitutions in the hemagglutinin (HA) gene can result in amino acid changes in the antigenic sites in the HA1 domain. 5 The rate of these substitutions is higher in HA1 than in HA2 or in the neuraminidase (NA) gene. 6 -8 We studied a population of children younger than 5 years and their parents to ascertain whether a child-to-parent mode of transmission would be supported by nucleotide sequencing of influenza viruses.
METHODS
We recruited children younger than 5 years who were enrolled in a burden of influenza study in east London, United Kingdom, during the 2002-2003 influenza season. 9 Ethics approval was granted by the North East London Research Ethics Committee. Influenza-positive children were identified by immunofluorescence (IF) assay of nasopharyngeal aspirate samples. Inclusion criteria for parents were fluency in English or Bangladeshi, ability to provide informed consent, absence of a contraindication to the taking of a nasal wash sample, and the development of symptoms within 14 days after the onset of symptoms in their child.
A nasal wash was obtained from symptomatic parents. One aliquot was examined by IF for influenza A and B, respiratory syncytial virus, adenovirus and parainfluenza 1, 2 and 3. The other aliquot was stored at 4°C before transfer to storage at Ϫ70°C and subsequently transported to the Health Protection Agency, Colindale.
For comparison, field viruses representative of influenza viruses circulating during 2002-2003 were also analyzed. Samples were first analyzed by multiplex nested reverse transcription-PCR (RT-PCR) to type and subtype the HA gene. 10 A multiplex PCR for the subtyping of the NA gene was performed using nested primer sets. 11 The nucleotide sequence of the HA1 and HA2 domains of the HA gene of influenza A viruses, and the coding region of the NA gene, were determined by amplification from cDNA, using a highfidelity DNA polymerase (Pfu Ultra, Stratagene, Netherlands). Both strands of purified amplicons were sequenced with appropriate PCR primers. 11, 12 Phylogenetic analysis of sequences was performed using Mega3. 13 Nucleotide sequences were submitted to the Los Alamos Influenza Sequence Database 14 and assigned unique accession numbers ISDN119037-ISDN119066.
RESULTS

Influenza Diagnosis by IF or PCR.
We recruited 9 children and 10 parents from 7 families ( Table 1) . Eight nasopharyngeal aspirate samples from these children were influenza A positive by IF and PCR examination. Influenza A H3N2 was detected in 7 samples and A H1 in one child. Families F1 and F2 were related and the children were in close contact. All other families were separate in time and space. We obtained nasal washes from 6 of 8 parents who became symptomatic after their children. Although nasal wash samples from all parents were negative by the IF assay for respiratory viruses, subsequent multiplex RT-PCR assays detected influenza A H3N2 in 4 of these samples. Nucleotide Sequence Analysis of the HA1 Domain of the HA Gene of Influenza A H3N2 Viruses. We obtained parent-child paired viruses from 3 families (F2, F4 and F6). In all 3 families the HA1 sequences of the influenza A H3N2 viruses analyzed from the family members were identical within that family (Fig. 1) . Sequences from 2 of the families (F2 and F4), and from the index cases from 2 families (F1 and F3), were closely related to A/Panama/2007/99 (Fig. 1) .
The HA1 nucleotide sequences of viruses from families F1, F2, F3 were identical and differed by 3 nucleotides from HA1 sequences from family F4. Of these 3 nucleotide differences, 2 were nonsynonymous and resulted in the amino acid substitutions V112 and E280K. The HA1 sequences from the other family (F6) were most closely related to the H3N2 variant, A/Fujian/411/2002. HA1 sequences from viruses in this family F6 differed by 29 -32 nucleotides from those analyzed from families F1, F2, F3 and F4, and by 14 -16 amino acid differences.
Eight of the 11 field isolates analyzed were genetically similar to A/Panama/2007/99-like viruses (Fig. 1 
DISCUSSION
We demonstrated family specific genetic homology in the HA1 domain of the HA gene of virus strains detected in 3 families with young children (F2, F4 and F6). The HA1 nucleotide sequences differed among these families by at least 3 nucleotides. In each family, a parent became ill 1-7 days after the index subject. This is consistent with a child-to-parent mode of transmission. We also found genetic homology in respiratory samples from child contacts who became ill within 1-8 days of each other, consistent with child-child transmission as well. The specificity of HA1 nucleotide sequencing in inferring transmission is higher than that of a clinical diagnosis, serology, culture, IF or PCR analysis of viral isolates. Our results are consistent with the results of Gubareva and colleagues 15 who demonstrated identical HA1 nucleotide sequences recovered from families infected with influenza. Our study was performed with genetically different circulating viruses and in children aged Ͻ5 years who were specifically excluded from this previous study.
The HA1 sequences of viruses detected in 3 families (F1, F2 and F3) were identical, although families F1 and F2 were related. Analysis of the HA2 sequences was not able to discriminate between viruses from F1, F2 and F3. When the analysis was extended to the NA gene of the viruses from families F1, F2 and F3, a single nucleotide difference distinguished the viruses from F1 and F2, from the virus detected in F3. The observed substitutions between the HA and NA sequences from families F1, F2, F3 and F4 were present in both strands using forward and reverse sequencing primers. The NA mutation that differentiated F3 from F1 and F2 was also confirmed by repeat sequencing from the original sample material. This study was limited by the small number of cases because of the low activity influenza season. Our use of IF to identify index cases missed children who were influenza-positive only on subsequent PCR testing. IF was used due to the shorter turn-around time compared with block-based reverse transcription PCR assay. 9 Despite the small sample size the isolates within families were more homologous than viruses isolated from sporadic cases in the same season.
The application of nucleotide sequencing in surveillance of influenza viruses should assist in the prediction and investigation of influenza transmission in clusters other than families such as day care or entire communities, and thus help us understand the impact of different vaccination and antiviral use strategies. M acrolide antibiotics have long been safe and effective choices for treatment of community-acquired respiratory-tract infections. During the past 15 years, however, resistance to the macrolides in Streptococcus pneumoniae and other respiratory-tract pathogens has increased coincident with their increased use. This observation has led some experts to recommend reducing macrolide use as a principal measure to limit the spread of macrolide resistance. [1] [2] [3] This strategy presupposes that the acquisition of macrolide-resistant pneumococci is associated specifically or disproportionately with antecedent macrolide exposure. To test this supposition, we studied longitudinally a group of children treated for acute otitis media (AOM) and measured the frequency with which organisms of differing susceptibilities to azithromycin and penicillin appeared in the nasopharynx during and shortly after therapy.
CHANGE IN PNEUMOCOCCAL SUSCEPTIBILITY TO
MATERIALS AND METHODS
The samples in the current study were a subset of those derived from a larger program examining the effects of antibiotics on the microbial colonization patterns of ambulatory children. 4 In the larger study, children aged 3 months to 7 years with a diagnosis of AOM were recruited from 16 suburban pediatric practices in the Cleveland, OH, metropolitan area. Enrolled children were randomized to receive amoxicillin (80 mg/kg/d in 2 divided doses), cefpro-
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Azithromycin-Resistant Pneumococci zil (50 mg/kg/d in 2 divided doses), azithromycin (10 mg/kg on the first day, followed by 5 mg/kg on each of the next 4 days), or a single intramuscular dose of ceftriaxone (50 mg/kg). Nasopharyngeal swab specimens were obtained at entry, and then on days 3-5, 10 -14, and 28 -30 after initiation of therapy, and were processed for the presence of S. pneumoniae as previously described. 4 Frozen stocks of pneumococcal isolates, archived during approximately the first-third and last-third of the study, constituted the organisms analyzed for the current study. The antibiotic susceptibility to azithromycin was determined by microdilution assay and to penicillin by E-test. Organisms were categorized as azithromycinnonsusceptible S. pneumoniae (ANSP) and penicillin-nonsusceptible S. pneumoniae (PNSP), if the minimal inhibitory concentrations (MIC) of the antibiotic were Ն1 g/mL and Ն0.1 g/mL, respectively, consistent with guidelines suggested by the National Committee for Clinical Laboratory Standards (recently renamed the Clinical and Laboratory Standards Institute). Organisms isolated from the same child were categorized as having "different susceptibilities" if the MICs to an antibiotic differed by Ͼ4-fold.
Serotyping was determined by the Quellung reaction, using antisera obtained from the Statens Serum Institute, Copenhagen. Clonal relationships were established by pulsed-filed gel electrophoresis (PFGE) using routine techniques. 5 The mechanism of resistance to macrolide antibiotics was determined by testing the organisms for the presence of the efflux pump mefE and the ribosomal methylase ermB by PCR, using previously described methods.
5
RESULTS
The larger study examining the differential effects of antibiotics on colonization by pneumococcus commenced in November 1999 and extended through 3 winter seasons. Three hundred fortyeight subjects, of 1009 enrolled, were colonized in the nasopharynx with pneumococcus on at least 1 of the 4 study visits. Frozen stocks of pneumococcal isolates were archived from 221 colonized children. Subjects from whom frozen specimens were available did not differ from those in whom isolates were not available with regard to age, day-care attendance, history of AOM in the past 30 days or the past 6 months, or treatment assignment (data not shown, all P Ͼ 0.21).
Eighty-seven of these 221 subjects had S. pneumoniae isolated from their nasopharynx on more than 1 study visit. In 3 instances, 1 of the organisms failed to grow from frozen stocks, and in 1, PFGE analysis was precluded because of autolysis of DNA. Organisms from the remaining 83 children were analyzed.
Sixty-six of the 83 children (79.5%) carried identical PFGE types through the period of observation, and 17 (20.5%) carried more than 1 PFGE type. Among the 66 subjects with repeated isolates of the same PFGE type, there was no instance in which there was a change in susceptibility pattern to either azithromycin or penicillin over successive study visits. In 20 of these 66 instances, the organism was susceptible to both penicillin and azithromycin, and in 38 the organism was nonsusceptible to both.
In the remaining 17 subjects, pneumococcal isolates successively cultured from the same child demonstrated discordant PFGE types. In all circumstances where the PFGE type changed, the serotype also changed. In 14 of 17 instances (Table 1) , susceptibility to penicillin, azithromycin, or both differed from the original isolate, whereas in the remaining 3 subjects, the isolates retained the same susceptibility pattern despite being derived from different PFGE types. In 9 of the 14 instances in which the susceptibility phenotype changed, the organism isolated later in the observation period was equally or more resistant to both penicillin and azithromycin than the 1 isolated earlier (subjects 1-9, Table 1 ). In 5 subjects, however, the later-isolated organism was more susceptible to penicillin or azithromycin or both (subjects 10 -14, Table 1 ). The appearance of a new PFGE type occurred in children receiving all 4 study treatments. Among subjects acquiring a PFGE type with an MIC to azithromycin higher than that measured in their original isolate, 3 were assigned to azithromycin, 2 to cefprozil, and 3 to ceftriaxone. New PFGE types that were nonsusceptible to azithromycin expressed a wide range of MICs and were positive for mef, for erm, and for both determinants.
DISCUSSION
The current report indicates that, in most instances, acquisition of ANSP is the result of the appearance of a new strain rather than acquisition of resistance by an old one. These observations suggest that, similar to PNSP, the mechanism of acquisition is eradication of susceptible organisms from the nasopharynx allowing 
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either new colonization or overgrowth of a pre-existing resistant subpopulation. Because eradication of susceptible pneumococci is common to many oral antibiotic regimens, it can be anticipated that community spread of ANSP will occur after exposures to several different antibiotic classes including but not limited to macrolides. This preliminary analysis was performed because the molecular basis for ␤-lactam and macrolide resistance is different, prompting us to question whether the dynamics of acquisition of PNSP and ANSP colonization might be different as well. ␤-Lactam resistance among S. pneumoniae is mediated by the expression of chromosomally-encoded abnormal penicillin binding proteins. 6 The molecular events leading to the generation of these proteins are rare. Consequently, the epidemiology of penicillin-resistant pneumococci is one characterized by the horizontal transmission of a small number of predominant strains. In most children, colonization by 1 pneumococcal serotype at least partially inhibits colonization by a second. The acquisition of PNSP by individuals receiving antibiotics is primarily the result of destabilization of the nasopharyngeal ecology, particularly eradication of penicillin-susceptible pneumococci, which in turn allows either overgrowth of a cocolonizing ␤-lactam-resistant clone or colonization by a new organism through horizontal transmission, presumably from a close contact.
By contrast, most macrolide resistance in pneumococcus is mediated either through expression of an erm ribosomal methylase or one of the mef family of efflux pumps. Unlike ␤-lactam resistance, both of these determinants potentially may be newly expressed in a given clone under antibiotic pressure. Expression of many of the erm and mef genes is inducible in the presence of macrolide, 7 and at least some of these genes are harbored on transmissible elements, 8 which may be exchanged among cocolonizing bacteria in the presence of antibiotic. These observations raise the possibility that macrolide/azalide resistance in pneumococcus arises principally from originally susceptible clones that then emerge resistant after antibiotic exposure. This possibility would strongly support restriction of azithromycin use as a strategy to contain the expansion of ANSP in the community.
Our data, however, did not support this latter event, but rather suggested that acquisition of PNSP and ANSP both occurred as a result of the appearance of a new PFGE type after destabilization of the nasopharygeal ecology caused by antibiotic exposure. Our data did not allow us to determine the relative propensity of the different treatment regimens to promote colonization by ANSP. The frequency of coincident resistance to penicillin and azithromycin seen in this and other studies, however, suggests that repopulation by ANSP strains regularly occurs after ␤-lactam exposure, and by PNSP after azithromycin exposure. Consistent with this speculation, studies conducted in Finland and Greece have documented an association between the regional frequency of macrolide-resistant pneumococci and local consumption of both macrolides and ␤-lactam drugs. 9, 10 The recommendation to limit azithromycin use as the principal strategy to decrease the spread of ANSP is based largely on studies correlating increased regional consumption of the drug with the population incidence of azithromycin resistance, 1-3 a design that is inherently inferential. It is probable that ANSP originally emerged as a result of macrolide and azalide exposure. With the established endemic presence of these strains in the community, however, the current study raises the possibility that they may disseminate even with significant reduction of azithromycin use unless attention is directed toward decreasing the use of other antibiotics as well. E fficacious interventions to prevent mother-to-child transmission (MTCT) of human immunodeficiency virus type 1 (HIV-1) have been developed: antiretroviral (ARV) prophylaxis, cesarean section before labor and before ruptured membranes (ECS), and complete avoidance of breast-feeding. 1 Such interventions have been recommended as part of guidelines for the management of HIV-1-infected women in various countries.
2-4 As a consequence, there has been a substantial reduction in MTCT of HIV-1 in many countries, including those in Latin America and in the Caribbean, [5] [6] and elimination of MTCT of HIV-1 is now considered a reasonable goal in certain settings. In previous analyses 7 of data from the National Institute of Child Health and Human Development (NICHD) International Site Development Initiative (NISDI) Perinatal Study, a prospective cohort study of HIV-1-infected women and their infants in Latin America and the Caribbean, 99% of women received ARVs during pregnancy (over 80% received 3-drug ARV combination regimens), 38% of the women delivered by ECS, and none of the infants was breast-fed. Two factors were suggestive of an association with an increased risk of MTCT of HIV-1: mothers not receiving ARVs at the time of enrollment into the study and infant low birth weight. Our objectives in this study were to describe cases of MTCT of HIV-1 occurring in this cohort, and to evaluate whether opportunities for the prevention of transmission were missed.
MATERIALS AND METHODS
The NISDI Perinatal Protocol is a prospective cohort study conducted at multiple clinical sites in Latin America and the Caribbean where ARVs for prevention of MTCT of HIV-1 and alternatives to breast milk (eg, infant formula) are available. 7 Enrollment into the NISDI Perinatal Protocol began in September 2002, and is ongoing. Maternal study visits are conducted during pregnancy, at labor/delivery, at hospital discharge after delivery, and postpartum at 6 -12 weeks and at 6 months. During these study visits, the women are interviewed, a physical examination is conducted, and laboratory studies are obtained (except at the labor/delivery and the 6 months postpartum visits). Physical examination of the infants is conducted, and laboratory studies obtained, at birth and at 6 -12 weeks and 6 months after birth.
The study population for this article consists of HIV-1-infected infants born to women enrolled in the NISDI Perinatal Protocol as of March 2006. Infants were categorized as HIV-1-infected if they had any 2 of the following (obtained from separate specimens): positive HIV-1 culture, positive HIV-1 DNA PCR assay, positive neutralizable HIV-1 p24 antigen assay, or quantitative HIV-1 RNA Ն1000 copies/mL. In the absence of breastfeeding, transmission was categorized as having occurred in utero or intrapartum according to 2 definitions. According to the first definition, transmission was presumed to have occurred in utero if one or more virologic assays were positive within the first 2 days of life. 
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Presumed intrapartum transmission was defined as negative virologic assays during the first week, with evidence of HIV-1 infection between 7 and 90 days of age. 8 According to the second definition, a child with the first positive HIV-1 assay Յ7 days of age was classified as having in utero infection. Intrapartum infection was defined as a negative HIV-1 assay at Յ7 days of age, with a first positive assay Ͼ7 days of age. 9 Missed opportunities for prevention were cases of MTCT where it is possible that different medical (ARV prophylaxis or treatment; complete avoidance of breastfeeding) and/or surgical (ECS) management would have prevented MTCT of HIV-1.
RESULTS
Between September 2002 and March 2006
, 988 HIV-1-infected women were enrolled, 950 (96.2%) of whom acquired HIV-1 infection through heterosexual contact. Of these 988 women, 911 had delivered live born infants and the others either were still pregnant or had other pregnancy outcomes. Of the live born infants, 820 had completed the 6-month visit, 8 of whom were HIV-1-infected ͓transmission rate, 0.98% (95% CI: 0.45-1.96%)͔. These 8 infants were born in Argentina (4 infants from 2 hospitals in Buenos Aires) or Brazil (1 infant from Rio de Janeiro, 2 infants from Ribeirao Preto, and 1 infant from Porto Alegre), and none was breast-fed. Other characteristics of the infants and their mothers are shown in Tables 1 and 2 . One woman reported alcohol use during pregnancy (case 2), whereas 3 women were smokers (cases 1, 6, 7) . None of the women reported any other substance abuse during pregnancy.
Of the 2 infants with presumed in utero transmission according to both definitions, one (case 1) was born to an asymptomatic smoker with a high plasma viral load (VL) copies/mL and a low CD4 ϩ count (CD4) at baseline who received a 3-drug ARV regimen beginning at 24 weeks gestation, but who did not show major improvement in VL or CD4 ϩ count. The other infant (case 2) was born to a woman who initiated a 3-drug ARV regimen at 30 weeks gestation. Both of these cases were considered missed opportunities The Pediatric Infectious Disease Journal • Volume 26, Number 7, July 2007 Transmission of HIV-1 (case 1: because the woman did not show significant improvement in VL or CD4 despite receipt of a combination ARV regimen for several weeks during pregnancy, and it is possible that more intensive ARV management could have resulted in an uninfected infant; case 2: because ARV prophylaxis was only initiated at 30 weeks gestation, and it is possible that transmission could have been prevented if ARV prophylaxis had been initiated earlier in pregnancy).
Of the 4 infants with presumed intrapartum transmission according to both definitions, 1 infant (case 3) was a low birth weight but term infant whose mother, although asymptomatic and with a low VL, had a decrease in her CD4 despite 2 combination ARV regimens during pregnancy. The next infant (case 4) was born to a woman who delivered vaginally but who had a VL of 11,151 at hospital discharge after delivery. Another infant (case 5) was born to a woman with extremely high VLs, CDC Class C disease, and with duration of ruptured membranes of 6 hours. Of note, this infant's twin (Twin B) was uninfected. The delivery was by cesarean section, with the primary indication being prevention of HIV-1 transmission. A third infant (case 6) was delivered by ECS (primary indication: prevention of HIV-1 transmission) to a mother who received only 2 weeks of zidovudine prophylaxis initiated at 28 weeks gestation (despite an extremely elevated VL at enrollment). The VL remained above 1000 copies/mL at the time of hospital discharge after delivery. These 3 cases (cases 4 -6) were considered missed opportunities ͓case 4: Because of the vaginal delivery, assuming a VL obtained prior to delivery would be similar to the VL at hospital discharge; ECS (if acceptable to the mother) might have prevented transmission; case 5: For the same rationale as for case 1; and case 6: Because only zidovudine was administered as prophylaxis beginning at 28 weeks, despite the very high VL at enrollment͔.
Of the 2 infants with unknown timing of transmission according to one definition 8 and in utero or intrapartum transmission according to the second definition, 9 one (case 7) was born after prolonged duration of ruptured membranes (Ͼ24 hours) and the mother had received only 2 weeks of zidovudine prophylaxis (beginning at 27 weeks) before delivery. The other infant (case 8) was born to a woman with a long duration of ruptured membranes (15 hours) and with a perineal laceration.
DISCUSSION
Numerous risk factors for MTCT of HIV have been identified or are under investigation. 1 General categories of risk factors include: the amount of virus to which the child is exposed (eg, higher maternal plasma VL), the duration of such exposure (eg, vaginal delivery, longer duration of ruptured membranes), factors facilitating the transfer of virus from mother to child (eg, chorioamnionitis), and the child's susceptibility to infection (eg, preterm birth and low birth weight). Although many different interventions to prevent MTCT of HIV-1 have been and are being investigated, efficacy has been demonstrated to date for only ARV prophylaxis, ECS, and avoidance of breast-feeding. In addition to these interventions, observational data strongly suggest that receipt of combination ARV regimens is associated with very low rates of transmission. Our observed transmission rate is very low-consistent with data from other studies of HIV-1-infected women who have access to ARVs not only for prevention of MTCT, but also for treatment of their own HIV-1 disease, who are receiving care at centers that provide cesarean section for prevention of MTCT as indicated, and who have access to replacement feeding for their infants such that breast-feeding can be completely avoided.
MTCT of HIV-1 can occur in utero, around the time of labor and delivery, or postnatally through breast-feeding. 10 None of the 8 HIV-1-infected infants breast-fed, and thus transmissions occurred in utero or intrapartum. Risk factors for in utero or intrapartum MTCT of HIV-1 were present in all of the 8 mother-infant pairs ͓including advanced maternal HIV-1 disease (high maternal VL, low maternal CD4 count, advanced maternal clinical HIV-1 disease), low birth weight, and/or preterm birth͔. However, in 5 of these 8 cases (cases 1, 2, 4 -6) there appeared to be missed opportunities for prevention of MTCT, ie, instances in which MTCT of HIV-1 might have been prevented with different medical (ARV prophylaxis or treatment) or surgical (ECS) management. Our results serve to emphasize the importance of ongoing training and education regarding prevention of MTCT of HIV-1, as well as continued research regarding mechanisms of and interventions to prevent such transmission.
W ith the advent of regimens to prevent mother-to-child transmission of human immunodeficiency virus (HIV-1) infection and highly active antiretroviral therapy, 1-5 mother-to-child transmission of HIV has declined significantly in the United States. 6, 7 Transmission of HIV infection from mother-to-child may occur in utero, at the time of delivery or postnatally through breast-feeding. 8, 9 In the United States, women known to be HIV-infected are advised against breast-feeding. However, this recommendation can only be followed if women are aware of their HIV status. Pregnant women may have higher rates of HIV seroconversion than other women. 10, 11 Hence, testing done early in pregnancy may not identify all women at risk for transmitting HIV to their infants, and repeat testing has been recommended. 12, 13 Furthermore, women infected postnatally may continue to breast-feed and unknowingly infect their infants.
We present a case of postnatally acquired HIV infection in a 6-month-old breast-fed infant presenting with fever and pancytopenia. Her mother tested negative for HIV in both the second and third trimesters of pregnancy and the child's New York State newborn screen was negative for HIV antibodies. Despite multiple previous negative tests, the mother tested positive for HIV after the child's diagnosis. Clinicians should have a high index of suspicion for HIV infection in children presenting with signs and symptoms of acquired immunodeficiency syndrome (AIDS), despite negative testing during pregnancy and the newborn period.
CASE REPORT
A 6-month-old girl was admitted to our hospital for further evaluation of pancytopenia after initially presenting to an outside hospital with a 2-day history of fever, rhinorrhea and bilateral eyelid swelling. She was a full-term, vaginally delivered, breast-fed infant. Her past medical history was remarkable for viral gastroenteritis at 3 months of age and immune thrombocytopenia purpura at 5 months of age, both requiring hospital admission. Her initial physical examination was remarkable only for white plaques on the buccal mucosa. Laboratory evaluation was remarkable for anemia, (hematocrit 23%), thrombocytopenia (platelets 117,000/mL) and elevated serum transaminase values: aspartate aminotransferase (AST) 436 units/liter, alanine aminotransferase (ALT) 111 units/liter.
She was transferred to our hospital for bone marrow biopsy, which was normal. The fever persisted for 1 week and she was treated empirically with piperacillin-tazobactam for 10 days despite negative cultures. On the 12th hospital day she developed a rash and evidence of hemolysis with an acute drop in her hematocrit from 27% to 21%, and a positive direct Coombs test. Her serum lactose dehydrogenase concentration rose to 4611 units/liter and AST to 1435 units/liter. Two days later she developed increased irritability and fever. A lumbar puncture was performed and revealed a total protein of 483 mg/dL, glucose of 58 mg/dL, 2 white blood cells/ mm 3 , and 0 red blood cells/mm 3 . She was treated empirically with ceftriaxone, acyclovir and lipid complex amphotericin B. Thirty-six hours later she appeared obtunded and a repeat lumbar puncture showed improved parameters, with total protein of 158 mg/dL and no increased leukocytosis. By the following day, her mental status improved remarkably. She was afebrile with a resolving hepatitis. Consent for HIV testing was obtained. HIV enzyme linked immunosorbent assay was positive, Western blot was indeterminate and HIV RNA viral load was Ͼ750,000 copies/mL. Trimethoprim-sulfamethoxazole was initiated several days later for Pneumocystis jéroveci pneumonia prophylaxis.
Within a week of her HIV diagnosis she developed tachypnea and worsening respiratory distress requiring continuous positive airway pressure. A bronchoscopy showed evidence of Pneumocystis jiroveci on silver stain and intranuclear inclusions consistent with cytomegalovirus (CMV). The dose of trimethoprim-sulfamethoxazole was increased and corticosteroid therapy was added with significant improvement. Antiretroviral therapy with lopinavirritonavir, stavudine and lamivudine was initiated. She was discharged to home to complete a 21-day course of trimethoprimsulfamethoxazole with steroid taper and to continue antiretroviral therapy.
However, within a week of discharge she presented with fever, tachypnea, lymphocytosis and a multilobar consolidation on chest tomography. Despite broad-spectrum antimicrobial and antifungal therapy, her respiratory status declined eventually requiring high frequency ventilation. A viral culture from her tracheal aspirate grew CMV thought to reflect viral shedding. At that time, her CD4 ϩ count had dropped from 2095 cells/L (56%) at her initial diagnosis to 407 (54%) and her HIV viral load had dropped from Ͼ750,000 to 29,851 copies/mL. Plasma CMV polymerase chain reaction (PCR) was Ͼ100,000 copies/mL. Induction therapy with ganciclovir followed by CMV immune globulin was initiated for CMV pneumonitis. The CMV PCR decreased to 1880 copies/mL after 2 weeks of The Pediatric Infectious Disease Journal • Volume 26, Number 7, July 2007 HIV Infection in Breast-fed Infant induction, and became undetectable after initiating maintenance therapy. She was transitioned to conventional ventilation 1 month after being hospitalized and was discharged a few weeks thereafter. Despite 6 months of highly active antiretroviral therapy, the patient's HIV RNA viral load remains at detectable levels. Her outpatient course has been complicated by an episode of varicella infection, renal tubular acidosis and developmental delay.
The infant's mother reported testing negative for HIV infection on 2 separate occasions during pregnancy. Review of the child's New York State newborn screen showed that routine testing for HIV-1 specific antibodies was negative. At our request, the sample was later screened for HIV by DNA PCR, which was also negative. At the time of diagnosis, the child had a positive enzyme linked immunosorbent assay, indeterminate Western blot and high viral load, all suggestive of acute infection. On further questioning, the child's mother reported a 2-week illness comprised of fever, sore throat and swollen glands when the child was approximately 2 months of age. Maternal HIV serologies were positive during the child's hospitalization. Given negative serologies during pregnancy and at the time of delivery, we suspect that this illness represented an acute retroviral syndrome in the mother and that the child was infected during an acute maternal seroconversion.
DISCUSSION
This case represents a rare report of acute HIV infection in a breast-fed infant in a developed country. It also reflects the rare occurrence of postnatal transmission of HIV infection during an acute maternal seroconversion. Since the advent of the use of zidovudine and more potent treatment regimens for HIV-infected pregnant women, [1] [2] [3] [4] [5] new infections among infants have become rare in the United States. 6, 7 Since 1995, the Centers for Disease Control and Prevention has recommended that HIV testing be routinely offered to all pregnant women in the United States.
14 In 1999 New York State implemented testing for HIV-1 antibodies as a routine part of the state newborn screen. In our case, testing for HIV antibodies both early and late in pregnancy and at the time of delivery was negative, suggesting that there was no maternal seroconversion by the time of delivery. Furthermore, DNA PCR testing on the sample provided for the newborn screen was also negative suggesting that the child was unlikely to have been infected in utero.
We hypothesize that this child's mother was infected some time in the postnatal period and that the child was infected at or close to the time of the mother's acute seroconversion. Our patient's prolonged viral syndrome, including fever, pancytopenia, hepatitis, encephalitis, and hemolysis may all be explained by an acute retroviral syndrome. 15 Whereas both acute HIV infection in adults [15] [16] [17] and the natural history of children infected in utero or perinatally has been well described, 18 -21 fewer reports exist of children undergoing acute seroconversion postnatally as a result of breast-feeding. 22 One report examining clinical signs and symptoms associated with acute seroconversion among breast-feeding African children found that 3 clinical signs/ symptoms, including a mononucleosis-like syndrome, dermatitis and generalized lymphadenopathy were independently associated with cases of acute HIV seroconversion as compared with controls.
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Despite a 6-month course of HAART, our patient's viral load remains detectable. Genotype testing has revealed that she has HIV-1 subtype AG, which is consistent with the parents' country of origin. Data suggest that AG recombinants may have up to a 2.5-fold greater change in IC 50 or IC 90 , depending on the protease inhibitor used, when compared with the non-Ghanaian subtype B protease. 23 However, given that our patient has done clinically well, we have not opted to change her regimen. Furthermore, there is limited pharmacokinetic information on other potent regimens in this age range and limited knowledge on optimal antiretroviral therapy for non-B subtypes to support a change in therapy.
C hronic granulomatous disease (CGD) is a genetic primary immunodeficiency disease of abnormal phagocytic function. The underlying defect is an inability of phagocytes to reduce molecular oxygen and create the reactive oxygen metabolites necessary for efficient intracellular killing activity. 1 Catalase positive organisms cause the majority of infections in CGD because only these pathogens survive inside CGD phagosomes. Catalase positive organisms include Staphylococcus, Serratia, Nocardia, Mycobacteria, and fungi including Aspergillus and Basidiomycetous fungi. [2] [3] [4] Fungal osteomyelitis comprises 22% of CGD patients with osteomyelitis, 1 and sacral osteomyelitis with Inonotus is a very rare presentation.
CASE REPORT
Our patient was diagnosed at age 1 year with an X-linked CGD after recurrent pneumonias, gastroenteritis and granuloma formation. He was given prophylactic trimethoprim-sulfamethoxazole at diagnosis, recombinant interferon ␥ at 8 years and itraconazole prophylactic therapy after treatment of an Aspergillus fumigatus osteomyelitis at 10 years. He later developed severe hemolytic anemia and vertebral osteomyelitis, which was treated with amphotericin B lipid complex and granulocyte infusions. The details of his early course are discussed elsewhere. 3 At 21 years of age, he developed a left paraspinal abscess (Fig. 1A , Online only; see www.pidj.com for Fig. 1A-G) while receiving itraconazole prophylaxis. An unidentified golden brown mold grew from tissue obtained during surgical drainage. It was initially considered a contaminant because it did not produce diagnostic structures on a variety of media and culture conditions suitable for known human pathogens. The abscess resolved with surgical drainage and antibiotic therapy but no specific antifungal therapy.
At 22 years, he developed a tender mass on his left lower back with no overlying erythema or neurologic compromise. He was afebrile with an erythrocyte sedimentation rate of 21 mm/h, had normal bilateral hip plain radiographs, and a CT scan of his chest, abdomen and pelvis with contrast revealed a 3 cm ϫ 7 cm ϫ 1.5 cm area of increased enhancement in the lumbosacral joint and the junction of the left lumbar spine. There was a mixed sclerotic and lytic process within the sacrum. At the sacral foramen, a small air bubble was noted. A MRI (Fig. 1B) showed extensive abnormal marrow signal in the sacrum with disease extending into the sacral foramina and intracanalicular fat at S1-S2. A left paraspinous lesion was noted at L5.
Biopsies performed with ultrasound guidance of the right hemisacrum, left paraspinal abscess and bone marrow were obtained and grew the same golden brown mold that had been isolated 9 months prior. The biopsy pathology showed necrotizing granulomatous inflammation and septate fungal organisms (Fig. 1C, D) . Molecular studies unequivocally identified the etiologic agent as Inonotus tropicalis. In vitro antifungal MIC data for amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin at 48 hours was 0.25, 0.25, 0.5, 1, and 2 g/L, respectively. Details of these studies are published elsewhere. 4 He was treated with amphotericin B lipid complex 200 mg IV daily and voriconazole 200 mg orally twice daily. He was discharged from the hospital on voriconazole monotherapy after 2 weeks. An MRI 3 months later suggested a new lesion in the left paraspinal muscles at T4 -5, an enlarging collection in the left paraspinous muscles T6 -7 and a fluid collection extending caudally in the left paraspinal/gluteal region (Fig. 1E) .
He was given amphotericin B lipid complex 200 mg IV thrice weekly, caspofungin 50 mg IV daily and voriconazole was continued. His fungal infection was stable on this regimen until he was admitted 6 months later for pneumonia. MRI of his thoracolumbar spine showed increased enhancement in the subcutaneous soft tissues overlying the left paraspinous musculature at L5/S1 and a 1-cm rim enhancing collection in the left posterior paraspinous musculature from T6 to T8. Bone scan was normal. The left parasacral lesion was incised and drained with isolation of Inonotus species.
After 3 weeks of noncompliance with IV caspofungin, he had enlargement and tenderness of the left parasacral lesion with overall progression on MRI with loculated abscesses in the left paraspinal muscles. Biopsy revealed epithelioid granulomas with scattered multinucleated giant cells and septate, partly degenerating hyphae. He continued triple antifungal therapy but developed the abscesses extended along the left upper buttock and the right piriformis on MRI. With compliance to medications, the parasacral abscess was culture negative for 4 months, but with noncompliance, subsequent cultures have been positive for I. tropicalis. Susceptibility studies have shown decreased sensitivity only to caspofungin with an increased 48 hour MIC (4 g/L). He has had intermittent drainage, swelling and pain in his left hip. Three years after triple antifungal therapy was initiated, there is still residual inflammation on MRI. (Fig. 1F, G) .
DISCUSSION
The case of I. tropicalis infection described here is unique because of the insidious onset of a slowly destructive sacral osteoThe Pediatric Infectious Disease Journal • Volume 26, Number 7, July 2007 Inonotus tropicalis Osteomyelitis myelitis associated with soft tissue abscesses. Aspergillus is the second most common pathogen in osteomyelitis in CGD after Serratia species. 1 When Aspergillus affects vertebral bodies, the clinical sequela in CGD patients involves paraparesis or paraplegia. 2, 5 Although Aspergillus is the most prevalent fungal infection in these patients, other fungi have also been reported. These include Paecilomyces variotii, Paecilomyces lilacinus, Acremonium strictum, Sarcinosporon inkin, Exophiala dermatitidis, Pseudallescheria boydii and Chrysosporium zonatum. Of these non-Aspergillus fungal infections in CGD, Paecilomyces species are most prevalent, comprising about 44% of non-Aspergillus fungal infections 6 and 8% of total CGD osteomyelitis cases. 1 The sites of involvement of Paecilomyces in CGD have included lung, bone, abdominal wall and soft tissue in a heel. 6 I. tropicalis mycosis was an unexpected finding in our CGD patient. I. tropicalis is a filamentous fungal species in the family Hymenochaetaceae and the class Basidiomycetes. It is ubiquitous and one of the largest genera of wood destroying fungi. The spectrum of documented infections reported for the basidiomycetes, namely Schizophyllum commune and Coprinus species, include endocarditis, meningitis, sinusitis, ulcerative lesions of the hard palate, fungal ball in the lung, allergic bronchopulmonary conditions, bronchial mucoid impaction and chronic respiratory disease. Although filamentous basidiomycetes fungi are being increasingly recognized, their definitive identification is problematic because many isolates do not initially produce diagnostic structures in culture. 7 Inonotus (also known as Phellinus) species have been studied for their potential antioxidant, antiangiogenic, 8 tumoricidal 9 and immunostimulatory effects.
10 Inonotus (Phellinus) rimosus extract was able to restore cisplatin-depleted renal catalase function, suggesting that the Inonotus species can produce catalase.
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Osteomyelitis in CGD tends to occur in the thoracic vertebrae, ribs, and metatarsals. Fungal or mycobacterial infection tends to result from direct spread of the infection from an adjacent focus of soft tissue infection. 3 Historically, treatment of fungal infection in CGD has included antifungal chemotherapy, surgical debridement of infected tissue and granulocyte transfusions, with the first 2 modalities typically required to eradicate fungal bone infection. We used only chemotherapy in our patient. Susceptibility studies have shown that this Inonotus species has remained susceptible to amphotericin B, itraconazole, voriconazole and posaconazole but that some resistance to caspofungin has developed over time. Since the clinical relevance of antifungal resistance and tolerance in vitro has not been well demonstrated in the literature, 12 and because of the nature of the underlying immunodeficiency in our patient, multidrug therapy seemed prudent. Granulocyte transfusions in CGD are supported by the principle that a small number of normal phagocytes may be able to compensate for the oxidative defect in CGD phagocytes, 13 but the efficacy of such treatments is unknown. This therapy was precluded in our patient who has the McLeod phenotype due to prior sensitization. 3 Surgical debridement was not a good option in this case because of the extensive mixed lytic-sclerotic destruction of the sacrum and tissue surrounding the sacral foramina. To date, the patient has had no neurologic sequelae from the infection, but the risk of extensive or even limited surgical debridement with possible sacral neurologic impairment exceeds the potential benefit of decreased organism burden. In one series, limited intralesional debridement effectively eradicated 5 of the 11 infections in autosomal CGD patients, but only 2 of 8 infections in X-linked CGD patients. 2 The prognosis for our patient is guarded. The Inonotus osteomyelitis has slightly improved on his current antifungal regimen but has not been eradicated. Bone marrow transplantation in CGD patients with extensive fungal disease can be very dangerous although successful cases have been reported. 14 The timing of transplantation is of critical importance. If transplantation is delayed to adolescence or later, the chances of invasive fungal infections, inflammatory complications and graft-versus-host disease increase. 15, 16 
